CHAN ZUCKERBERG BIOHUB NETWORK
DEAD

Serial Number

99060150

Owner

Chan Zuckerberg Initiative, LLC

Attorney

Anthony Malutta

Filing Date

Feb 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CHAN ZUCKERBERG BIOHUB NETWORK Trademark

Serial Number: 99060150

CHAN ZUCKERBERG BIOHUB NETWORK is a trademark filed by Chan Zuckerberg Initiative, LLC on February 27, 2025. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Chan Zuckerberg Initiative, LLC

Redwood City, CA 94063

Entity Type: 16

Trademark Details

Filing Date

February 27, 2025

Registration Date

Not Registered

Goods & Services

Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; research, development and design of biomedical technologies and products for others; development and design of computer software; scientific research; scientific research in the field of medicine; medical research; biomedical research; biotechnology research; technology services, namely, technological research and development in the field of biomedical imaging and imaging technology; providing information about scientific, medical, biomedical and biotechnology research; providing information about imaging technology; providing facilities for scientific, medical, biomedical and biotechnology research, namely, rental of laboratory facilities; consulting in the fields of biomedical imaging and imaging technology, biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; providing a website featuring information in the field of biomedical imaging and imaging technology; research and development of vaccines and medicines; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; biotechnology research services, and research and development of new products in the field of gene therapeutics; design of genetic research tools and systems for others; compiling data for research purposes in the field of medical science; scientific research and development, namely, development of new scientific computational technologies to predict positive and negative regulators of gene network function; developing new technology for others in the field of computational genomics; genome sequencing services for scientific and research purposes; providing genetic sequencing and consulting services for clinical research purposes; genetic testing for medical research purposes; medical diagnostic testing, monitoring and reporting services for research purposes; providing genetic sequencing and consulting services for medical research purposes; scientific laboratory services relating to the isolation and cultivation of human tissues and cells; research and development services in the field of immunology; research and development in the field of microorganisms and cells; scientific research for medical purposes in the area of infectious, cancerous, and neurodegenerative diseases; research in the field of cell engineering technology

Promoting technical and scientific investigation, research, and experimentation in the field of biomedical imaging and imaging technology; promoting the exchange of information and resources within the scientific and medical research community and the technology industry to achieve advances in the field of biomedical imaging and imaging technology; promoting public awareness of the biomedical imaging research field; administration and management of research grants

Educational services, namely, arranging and conducting seminars, workshops, colloquia, lectures, non-downloadable webinars, non-downloadable multimedia program series and training in the fields of biomedical research, biotechnology, bioinformatics, bioengineering, data analytics and data science; educational services, namely, providing educational conferences, symposiums and round-table discussions in the field of biomedical imaging and imaging technology; providing online searchable educational computer databases in the field of biomedical imaging and imaging technology; non-downloadable electronic publications, namely, letters, newsletters, articles, news stories, blogs and fact sheets in the field of biomedical imaging and imaging technology; providing a website featuring blogs in the fields of biomedical research, biotechnology, bioinformatics, bioengineering, data analytics and data science

Medical diagnostic testing, monitoring and reporting services for research purposes; consulting services in the fields of diagnostic medical testing

Financial services, namely, providing grants and funding in the field of biomedical imaging and imaging technology research; funds investment, namely, fund investment services in imaging technology products; funds investment, namely, fund investment services in imaging technology development projects; providing funding, namely, providing grants in the fields of scientific medical and biomedical research

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 25, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 25, 2026 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 7, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 7, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 7, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 31, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 31, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 25, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 25, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 25, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 25, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 22, 2025 NWOS
NEW APPLICATION ENTERED
Feb 27, 2025 NWAP
APPLICATION FILING RECEIPT MAILED
Feb 27, 2025 MAFR